Cooperative Groups Advised To Plan For Future Of Less Funding from NCI
In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow
ODAC Recommends Ethyol, DaunoXome For FDA Approval
ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation
Cancer Panel Urges Improved Funding For Basic Science
FDA, NIH Streamline Approvals For Gene Therapy Studies
Report Criticizes NIH Grant Review
NIH Policy On Diversity In Sponsored Meetings
Trending Stories
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Cancer Center at Illinois is recognized as NCI Basic Cancer Center, becoming the first new institution to earn this designation in 40 years
- Most Favored Nation drug pricing could put China on top
- NCI Director Letai wants you to know: Grant money is flowing again post-government shutdown
- Self-collection kits for HPV are among innovations adding momentum to eradication of cervical cancer
A kit for at-home unsupervised self-collection clears FDA finish line
